Insertion of two animo acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs

AIDS

Volumn 13, Issue 1, 1999, Pages 75-80

  De Jong, J Jacques ^b   Goudsmit, Jaap ^a   Lukashov, Vladimir V ^b   Hillebrand, Milly E ^b   Baan, Elly ^b   Huismans, Raymond ^b   Danner, Sven A ^a   Ten Veen, Jacobus H ^b   De Wolf, Frank ^b   Jurriaans, Suzanne ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

Antiretroviral therapy; Drug resistant mutations; Multidrug resistance; Nucleoside reverse transcriptase inhibitors; Zidovudine

Indexed keywords

AMINO ACID; ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE; STAVUDINE; TYROSINE; ZALCITABINE; ZIDOVUDINE; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; DRUG SENSITIVITY; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS RECOMBINANT; ANTIBIOTIC RESISTANCE; CASE REPORT; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; VIROLOGY;

ADULT; AMINO ACIDS; ANTI-HIV AGENTS; DIDEOXYNUCLEOSIDES; DRUG RESISTANCE, MICROBIAL; GENOTYPE; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; NEVIRAPINE; PHENOTYPE; REVERSE TRANSCRIPTASE INHIBITORS; TYROSINE;

EID: 0033552832     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199901140-00010     Document Type: Article

References (20)

1. 1. Hirsch MS, Conway B, D'Aquila RT, et al.: Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society-USA Panel. JAMA 1998, 279:1984-1991.
2. 2. Moyle GJ: Current knowledge of HIV-1 reverse transcriptase mutations selected during nucleoside analogue therapy: the potential to use resistance data to guide clinical decisions. J Antimicrob Chemother 1997, 40:765-777.
3. 3. Brown AJ, Richman DD: HIV-1: gambling on the evolution of drug resistance? Nat Med 1997, 3:268-271.
4. 4. De Wolf F, De Jong JJ, Hertogs K, Danner SA, Lange JM, Goudsmit J: Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/1997. Ned Tijdschr Geneeskd 1998, 142:573-578.
5. 5. Hertogs K, De Bethune MP, Miller V, et al.: A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother 1998, 42:269-276.
6. 6. Japour AJ, Mayers DL, Johnson VA, et al. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group. Antimicrob Agents Chemother 1993, 37:1095-1101.
7. 7. Kaye S, Loveday C, Tedder RS: A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine. J Med Virol 1992, 37:241-246.
8. 8. Gingeras TR, Prodanovich P, Latimer T, Guatelli JC, Richman DD, Barringer KJ: Use of self-sustained sequence replication amplification reaction to analyze and detect mutations in zidovudine-resistant human immunodeficiency virus. J Infect Dis 1991, 164:1066-1074.
9. 9. Stuyver L, Wyseur A, Rombout A, et al.: Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother 1997, 41:284-291.
10. 10. De Wolf F, Hogervorst E, Goudsmit J, et al.: Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res Hum Retroviruses 1994, 10:1387-1400.
11. 11. Lukashov VV, Kuiken CL, Goudsmit J: Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J Virol 1995, 69:6911-6916.
12. 12. Iversen AK, Shafer RW, Wehrly K, et al.: Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J Virol 1996, 70:1086-1090.
13. 13. Shirasaka T, Kavlick MF, Ueno T, et al.: Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc Natl Acad Sci U S A 1995, 92:2398-2402.
14. 14. Ross L, Johnson M, Graham N, Shaefer M, Griswold M, St Clair M: An in frame insertion into the HIV RT gene is associated with a decreased patient viral load. Fifth Conference on Retroviruses and Opportunistic Infections. February 1998, Chicago [abstract 679].
15. 15. De Antoni A, Foli A, Lisziewicz J, Lori F: Mutations in the pol gene of human immunodeficiency virus type 1 in infected patients receiving didanosine and hydroxyurea combination therapy. J Infect Dis 1997, 176:899-903.
16. 16. Lin PF, Samanta H, Rose RE, et al.: Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy. J Infect Dis 1994, 170:1157-1164.
17. 17. Deminie CA, Bechtold CM, Riccardi K, et al.: Clinical HIV-1 isolates remain sensitive to stavudine following prolonged therapy [letter]. AIDS 1998, 12:110-112.
18. 18. Soriano V, Dietrich U, Villalba N, et al.: Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy [letter]. AIDS 1997, 11:696-697.
19. 19. Whitcomb JM, Limoli K, Wrin T, et al.: Phenotypic and genotypic analysis of stavudine (d4T) resistant isolates of HIV-1. Second International Workshop on HIV Drug Resistance and Treatment Strategies. Lake Maggiore, June 1998 [abstract 58].
20. 20. Human Retroviruses and AIDS 1997. Edited by Korber B, Foley B, Leitner T, et al.: Los Alamos, New Mexico, USA: Theoretical Biology and Biophysics, Los Alamos National Laboratory; 1997.